Edit Reading

Back to List

Basic Information

Title

Please enter a title.

URL

Please enter a valid URL.

Date

カテゴリID

画像ファイル名

単語数（空欄の場合は本文から自動計算）空欄の場合は本文から自動計算されます。本文が空欄の場合は既存の値が保持されます。

統計情報

現在の単語数: 188語

読了回数: 0回

作成日: 2022/11/22 23:24

更新日: 2025/12/09 11:17

本文

Japan has approved use of a pill that doctors who treat COVID-19 have been waiting for and can prescribe to anyone no matter how mild their symptoms.
                
Japanese Health Minister Kato Katsunobu told reporters on Tuesday evening that experts approved emergency authorization of Shionogi&#039;s oral drug Xokova. He added that he had just approved it in his capacity as minister of health, labor and welfare.
                
The ministry&#039;s expert panel had looked at clinical data and found evidence that the domestically developed pill is effective against fever and other COVID symptoms.
                
Two other oral medications are currently approved for mild cases. Both were developed in the US and are intended only for patients at high risk of developing severe symptoms.
                
Doctors say it&#039;s difficult to predict who COVID will hit hard, and called for a drug they could prescribe more broadly. Health officials plan to distribute Xokova nationwide, with hospitals getting enough doses for one million patients.
                
Japan is now facing an 8th COVID wave. More than 120,000 infections were reported nationwide on Tuesday, for the 18th straight day of week-on-week increase. Three northern prefectures confirmed record-high case counts.

メモ

メモ・感想

キャンセル

Edit Reading

Basic Information

統計情報

本文

メモ

Send Report